Magnetic resonance imaging (MRI) is the standard imaging technique in the diagnosis of primary brain lesions. However, novel PET imaging techniques such as choline-PET are currently being investigated in the clinic to characterize tumour metabolism. In this study, we compared pharmacokinetic parameters resulting from the modelling of dynamic contrast enhanced (DCE) MRI data, using the Tofts model (TM) and shutter speed model (SSM), with metabolic macroparameters derived from the application of the spectral analysis (SA) to dynamic PET data. We observe a correlation between some pharmacokinetic parameters and the parameters obtained through spectral analysis of the dynamic choline-PET data.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords